These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15028071)

  • 1. Atrial tachyarrhythmia recurrence temporal patterns in bradycardia patients implanted with antitachycardia pacemakers.
    Ricci R; Santini M; Padeletti L; Boriani G; Capucci A; Botto G; Gulizia M; Inama G; Galati A; Solimene F; Pepe M; Grammatico A
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):44-51. PubMed ID: 15028071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers.
    Capucci A; Santini M; Padeletti L; Gulizia M; Botto G; Boriani G; Ricci R; Favale S; Zolezzi F; Di Belardino N; Molon G; Drago F; Villani GQ; Mazzini E; Vimercati M; Grammatico A;
    J Am Coll Cardiol; 2005 Nov; 46(10):1913-20. PubMed ID: 16286180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Boriani G; Piccione G; DiGiovanni N; Colletti A; Puntrello C; Butera G; Vasco C; Vaccaro I; Scardace G; Grammatico A;
    Europace; 2006 Jul; 8(7):465-73. PubMed ID: 16798758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of structural heart disease on characteristics of atrial fibrillation recurrence in patients with dual-chamber pacemakers.
    Reiter MJ; Harsch M; Lung TH; Munneke D; Kim MH; Shalaby A;
    J Electrocardiol; 2009; 42(2):128-35. PubMed ID: 18976775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker.
    Boriani G; Bertaglia E; Carboni A; Latini R; Biffi M; Martignani C; Sciotto F; Branzi A
    Int J Cardiol; 2005 Sep; 104(1):73-6. PubMed ID: 16137513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of atrial tachyarrhythmias in patients treated by cardiac resynchronization (from the Prospective, Multicenter Mona Lisa Study).
    Marijon E; Jacob S; Mouton E; Defaye P; Piot O; Delarche N; Dennetiere S; Galley D; Le Franc P; Appl U; Guyomar Y; Albenque JP; Chevalier P; Boveda S;
    Am J Cardiol; 2010 Sep; 106(5):688-93. PubMed ID: 20723647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of antitachycardia pacemaker on atrial tachyarrhythmia detection, prevention and termination].
    Bai R; Wang TM; Lin L; Kam R; Wee St; Wang L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):333-7. PubMed ID: 16776927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias.
    Saksena S; Hettrick DA; Koehler JL; Grammatico A; Padeletti L
    Am Heart J; 2007 Nov; 154(5):884-92. PubMed ID: 17967594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overdrive versus conventional or closed-loop rate modulation pacing in the prevention of atrial tachyarrhythmias in Brady-Tachy syndrome: on behalf of the Burden II Study Group.
    Puglisi A; Favale S; Scipione P; Melissano D; Pavia L; Ascani F; Elia M; Scaccia A; Sagone A; Castaldi B; Musacchio E; Botto GL;
    Pacing Clin Electrophysiol; 2008 Nov; 31(11):1443-55. PubMed ID: 18950302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into long-term follow-up of atrial fibrillation ablation: full disclosure by an implantable pacemaker device.
    Martinek M; Aichinger J; Nesser HJ; Ziegler PD; Purerfellner H
    J Cardiovasc Electrophysiol; 2007 Aug; 18(8):818-23. PubMed ID: 17573835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic pacing for atrial fibrillation prevention in sinus node disease: long-term results.
    Ricci R; Pignalberi C; Santini L; Magris B; Russo M; Grovale N; de Santo T; Santini M
    Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S54-60. PubMed ID: 17169134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal variability of atrial tachyarrhythmia burden in bradycardia-tachycardia syndrome patients.
    Padeletti L; Santini M; Boriani G; Botto G; Capucci A; Gulizia M; Ricci R; Spampinato A; Pieragnoli P; Warman E; Vimercati M; Grammatico A
    Eur Heart J; 2005 Jan; 26(2):165-72. PubMed ID: 15618073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary vein isolation for atrial fibrillation in patients with symptomatic sinus bradycardia or pauses.
    Khaykin Y; Marrouche NF; Martin DO; Saliba W; Schweikert R; Wexman M; Strunk B; Beheiry S; Saad E; Bhargava M; Burkhardt JD; Joseph G; Tchou P; Natale A
    J Cardiovasc Electrophysiol; 2004 Jul; 15(7):784-9. PubMed ID: 15250863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Drug And Pace Health cliNical Evaluation (DAPHNE) study: a randomized trial comparing sotalol versus beta-blockers to treat symptomatic atrial fibrillation in patients with brady-tachycardia syndrome implanted with an antitachycardia pacemaker.
    Capucci A; Botto G; Molon G; Spampinato A; Favale S; Proclemer A; Porfilio A; Marotta T; Vimercati M; Boriani G;
    Am Heart J; 2008 Aug; 156(2):373.e1-8. PubMed ID: 18657671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Device treatment of atrial tachycardia--minor additional effect of repeating pacing sequences.
    Schuster P; Faerestrand S; Ohm OJ
    Int J Cardiol; 2005 Sep; 104(1):10-4. PubMed ID: 16137503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of paroxysmal atrial fibrillation in patients with implanted pacemakers: relationship to symptoms and other variables.
    Quirino G; Giammaria M; Corbucci G; Pistelli P; Turri E; Mazza A; Perucca A; Checchinato C; Dalmasso M; Barold SS
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):91-8. PubMed ID: 19140918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal patterns of ventricular tachyarrhythmia recurrences follow a Weibull distribution.
    Wood MA; Gunderson B; Xia A; Zhou X; Padmanabhan V; Ellenbogen KA
    J Cardiovasc Electrophysiol; 2005 Feb; 16(2):181-5. PubMed ID: 15720457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: a prospective randomized trial.
    Tsai CT; Lai LP; Hwang JJ; Wang YC; Chiang FT; Lin JL
    Am Heart J; 2008 Jul; 156(1):65-70. PubMed ID: 18585498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of atrial arrhythmias detected by permanent pacemakers (PPM) post-pulmonary vein antrum isolation (PVAI) for atrial fibrillation (AF): correlation with symptomatic recurrence.
    Verma A; Minor S; Kilicaslan F; Patel D; Hao S; Beheiry S; Lakkireddy D; Elayi SC; Cummings J; Martin DO; Burkhardt JD; Schweikert RA; Saliba W; Tchou PJ; Natale A
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):601-6. PubMed ID: 17428271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.